Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1989 1
1993 4
1994 1
1996 2
1998 1
1999 1
2000 2
2001 4
2002 4
2003 7
2004 9
2005 8
2006 18
2007 17
2008 11
2009 17
2010 12
2011 18
2012 15
2013 28
2014 44
2015 53
2016 60
2017 48
2018 57
2019 63
2020 63
2021 67
2022 75
2023 68
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

710 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: Raiane
Page 1
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, Hermans MP, Pandey RC, Ray KK, Tokgözoglu L, Zambon A, Berrou JP, Farnier M. Raja V, et al. Atherosclerosis. 2023 Oct;383:117312. doi: 10.1016/j.atherosclerosis.2023.117312. Epub 2023 Sep 30. Atherosclerosis. 2023. PMID: 37826864 Free article. Review.
They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attribu …
They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. …
Management of diabetic ketoacidosis.
Besen BAMP, Ranzani OT, Singer M. Besen BAMP, et al. Intensive Care Med. 2023 Jan;49(1):95-98. doi: 10.1007/s00134-022-06894-9. Epub 2022 Sep 27. Intensive Care Med. 2023. PMID: 36166056 No abstract available.
Targeting cardiovascular inflammation: next steps in clinical translation.
Lawler PR, Bhatt DL, Godoy LC, Lüscher TF, Bonow RO, Verma S, Ridker PM. Lawler PR, et al. Eur Heart J. 2021 Jan 1;42(1):113-131. doi: 10.1093/eurheartj/ehaa099. Eur Heart J. 2021. PMID: 32176778 Review.
A large body of evidence has accumulated supporting the use of high-sensitivity C-reactive protein (hsCRP) as a clinical measure of inflammation. ...
A large body of evidence has accumulated supporting the use of high-sensitivity C-reactive protein (hsCRP) as a clinical measure of i …
Case 297.
Kanas AF, Fenelon SS, Santos JMMM, Coelho RF, Guglielmetti GB, Nahas WC, Viana PCC. Kanas AF, et al. Radiology. 2021 Sep;300(3):725-729. doi: 10.1148/radiol.2021202948. Radiology. 2021. PMID: 34424788
A persistent wheeze.
de Aguiar Mendes B, Santos JD, Figueiredo CL, Calheiros Cabral M, Santos Gerardo RL, Mineiro MA, Cardoso JAD. de Aguiar Mendes B, et al. Breathe (Sheff). 2021 Jun;17(2):210036. doi: 10.1183/20734735.0036-2021. Breathe (Sheff). 2021. PMID: 34295429 Free PMC article.
Studies on the synthesis of 1'-CN-triazolyl-C-ribosides.
Bozinovic N, Aguiar VM, Ferry A, Gallier F, Lubin-Germain N, Uziel J, Miranda LSME. Bozinovic N, et al. Org Biomol Chem. 2022 Sep 21;20(36):7261-7269. doi: 10.1039/d2ob01403c. Org Biomol Chem. 2022. PMID: 36069280
The search for broad-spectrum antiviral compounds is a continuous mandatory effort. The recent approval of the first C-nucleoside carrying a nitrile as a substituent at the C1' position of the ribose ring has raised interest in this underexplored substitution pattern. We h …
The search for broad-spectrum antiviral compounds is a continuous mandatory effort. The recent approval of the first C-nucleoside car …
SELNET clinical practice guidelines for bone sarcoma.
Blay JY, Palmerini E, Bollard J, Aguiar S, Angel M, Araya B, Badilla R, Bernabeu D, Campos F, Chs CS, Carvajal Montoya A, Casavilca-Zambrano S, Castro-Oliden 5th, Chacón M, Clara-Altamirano MA, Collini P, Correa Genoroso R, Costa FD, Cuellar M, Dei Tos AP, Dominguez Malagon HR, Donati DM, Dufresne A, Eriksson M, Farias-Loza M, Frezza AM, Frisoni T, Garcia-Ortega DY, Gerderblom H, Gouin F, Gómez-Mateo MC, Gronchi A, Haro J, Hindi N, Huanca L, Jimenez N, Karanian M, Kasper B, Lopes A, Lopes David BB, Lopez-Pousa A, Lutter G, Maki RG, Martinez-Said H, Martinez-Tlahuel JL, Mello CA, Morales Pérez JM, Moura DS, Nakagawa SA, Nascimento AG, Ortiz-Cruz EJ, Patel S, Pfluger Y, Provenzano S, Righi A, Rodriguez A, Santos TG, Scotlandi K, Mlg S, Soulé T, Stacchiotti S, Valverde CM, Waisberg F, Zamora Estrada E, Martin-Broto J. Blay JY, et al. Crit Rev Oncol Hematol. 2022 Jun;174:103685. doi: 10.1016/j.critrevonc.2022.103685. Epub 2022 Apr 21. Crit Rev Oncol Hematol. 2022. PMID: 35460913 Free article. Review.
Dyslipidemia: A Narrative Review on Pharmacotherapy.
de Oliveira LLH, de Assis ACR, Giraldez VZR, Scudeler TL, Soares PR. de Oliveira LLH, et al. Pharmaceuticals (Basel). 2024 Feb 23;17(3):289. doi: 10.3390/ph17030289. Pharmaceuticals (Basel). 2024. PMID: 38543075 Free PMC article. Review.
Current guidelines for treating dyslipidemia focus on low-density lipoprotein-cholesterol (LDL-C). Despite advances in the pharmacotherapy of atherosclerosis, the most successful agents used to treat this disease-statins-remain insufficient in the primary or secondary prev …
Current guidelines for treating dyslipidemia focus on low-density lipoprotein-cholesterol (LDL-C). Despite advances in the pharmacoth …
Dural-based lesions: is it a meningioma?
Nagai Yamaki V, de Souza Godoy LF, Alencar Bandeira G, Tavares Lucato L, Correa Lordelo G, Fontoura Solla DJ, Santana Neville I, Jacobsen Teixeira M, Silva Paiva W. Nagai Yamaki V, et al. Neuroradiology. 2021 Aug;63(8):1215-1225. doi: 10.1007/s00234-021-02632-y. Epub 2021 Jan 18. Neuroradiology. 2021. PMID: 33459822
The following imaging characteristics were evaluated on CT and MRI: (a) bone erosion; (b) hyperintensity on T2WI; (c) hypointensity on T2WI; (d) bone destruction; (e) dural tail; (f) leptomeningeal involvement; (g) pattern of contrast enhancement; (h) dural displacement si …
The following imaging characteristics were evaluated on CT and MRI: (a) bone erosion; (b) hyperintensity on T2WI; (c) hypointensity o …
710 results